BioVie Inc.

1 in Phase 3

Quick facts

Phase 3 pipeline

NE3107 · Neurology
NE3107 is a small-molecule inhibitor of translocator protein (TSPO) that crosses the blood-brain barrier to reduce neuroinflammation and oxidative stress in the central nervous system.

Phase 2 pipeline

Terlipressin acetate continuous infusion

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: